Stepping Up Asthma Control for Effective Management

Slides:



Advertisements
Similar presentations
PROBLEMS OF ASTHMA MANAGEMENT IN PAKISTAN. BURDEN OF ASTHMA ASTHMA IS ONE OF THE MOST COMMON CHRONIC DISEASE WORLDWIDE PREVALENCE INCREASING IN MANY COUNTRIES.
Advertisements

Immunology of Asthma through Biologics Private Practice & St Michael’s Hospital Lecturer, Division of Clinical Immunology & Allergy Department of Medicine,
Asthma Management Pathophysiology and Management University of Utah Center for Emergency Programs and The Utah Asthma Program.
Acute and chronic management of childhood asthma
The Patient Experience With Systemic Lupus Erythematosus
Copyright © 2015 by the American Osteopathic Association.
Moderate-to-Severe Asthma Management
Overview The Burden of COPD Main Challenges in the Diagnosis of COPD.
Practical Recommendations for COPD:
Pseudomonas Infection in Cystic Fibrosis
Treatment Strategies in Mild to Moderate COPD
RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL
Making Decisions With Your Osteoarthritis Patients
Starting Strong: Initial Evaluation of the Patient With HCV
Management of Mild to Moderate Asthma
The Clinical Enigma of Cardiogenic Shock
Severe Asthma.
Heart Rate, HF Admissions, and Readmissions
Understanding Biologics
COPD Management.
Clinical Review.
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
The Nurse View: Best Practices in Advanced Non-Small Cell Lung Cancer
Advances in Dyslipidemia: What Have We Learned From ACC 2017
Atopic Dermatitis Treatment Landscape
Chronic Idiopathic Urticaria
IL-17 Inhibitors in the Management of Psoriatic Disease
Addressing Disease Burden in Asthma
When Would You Use Single Inhaler Triple Therapy in COPD?
Combination Inhaled Therapy in COPD: The Impact of Recent Data
Assessing the Risk for Stroke in Patients With Atrial Fibrillation
Are We Closer to Personalized Medicine in MS?
Pharmacist Perspectives on Novel Agents in Multiple Myeloma
Overview. Maximizing the Safety of CAR T-Cell Therapy: Prevention, Early Recognition, and Management.
Program Goals. Treatment-Naive Patients With PAH What Do We Know and What Choices Do We Have?
Mild to Moderate Asthma
Therapeutic Strategies in COPD Focus on Patient Characteristics and Drug Delivery.
PCSK9 Inhibitors – A Leap in the Evolution of Dyslipidemia Management?
Radical New Concepts in Lipid Management
When Is Biologic Therapy Appropriate for HS?
Advances in Multiple Myeloma: Data Highlights and Analysis from the 2015 Hematology/Oncology Conferences.
Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.
Monoclonal Antibodies in CVD: What Does the Future Hold?
Understanding and Addressing the Needs of Patients With AD
Advances in Severe Asthma Management
New Horizons in Cystic Fibrosis Clinical Developments From Fall 2014
Challenges in Severe Asthma
The Rising Cost of Healthcare and Potential Impact of Biosimilars
EGPA.
Severe Asthma and Comorbidities
The Changing Field of Melanoma: Ipilimumab.
The Adherence Challenge in Schizophrenia Roles of Current and Emerging Therapies.
Addressing Treatment Challenges in Cystic Fibrosis
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.
Incorporating Prostacyclins Into Practice
Challenges in LA SCCHN.
Inhaled Antibiotics for Patients With CF in the Era of CFTR Modulators
Assessing the Burden of Hyperkalemia
New Lipid-Lowering Therapies
Pathogenesis of IBD, and the Role of Biologic Therapies
Assessing the Burden of Hyperkalemia
MS, Age, and Immune Function
Practical Recommendations for COPD:
Monoclonal Antibodies in Migraine Prevention: What the Primary Care Physician Needs to Know.
The Asthma Treatment Gap
Exploring the Role of Biologics in Reducing Oral Corticosteroid Use in Severe Asthma.
Agenda. Diagnosis, Assessment, and Treatment of the COPD Patient in Primary Care.
Foundations of Asthma.
Foundations of Asthma.
Presentation transcript:

Stepping Up Asthma Control for Effective Management

Asthma Is a Growing Problem

Incidence of Uncontrolled Asthma

Prevalence of Uncontrolled Asthma Across Different Practices

Burden Incidence in Controlled vs Uncontrolled Asthma

Costs Associated With Uncontrolled Asthma

Patient-Related Challenges

The Role of Inflammation in Asthma

Signs of Lack of Asthma Control

Signs of Lack of Asthma Control (cont)

The Asthma Control Test

Assessing Severe Exacerbations

Targeting the Inflammation in Asthma

Inhaled Corticosteroids

Leukotriene Modifiers

Monoclonal Antibodies Omalizumab

Monoclonal Antibodies Investigational

Ongoing Management Challenges

Trends in Asthma Therapy

Abbreviations

References

References (cont)

References (cont)

References (cont)